How to cite item

Impact of non-invasive anatomical testing on optimal medical prescription in patients with suspected coronary artery disease

  
@article{CDT25834,
	author = {Stijn Devuyst and Arno Gigase and Jerrold Spapen and Sofie Brouwers and Thomas Couck and Jeroen Sonck and Takuya Mizukami and Carlo Gigante and Herbert de Raedt and Dan Schelfaut and Ward Heggermont and Bernard De Bruyne and Martin Penicka and Guy Van Camp and Carlos Collet},
	title = {Impact of non-invasive anatomical testing on optimal medical prescription in patients with suspected coronary artery disease},
	journal = {Cardiovascular Diagnosis and Therapy},
	volume = {9},
	number = {3},
	year = {2019},
	keywords = {},
	abstract = {Background: Compared to functional testing, coronary computed tomography angiography (CTA) improves clinical outcomes in patients with suspected coronary artery disease (CAD). This is thought to be the result of an increased prescription of preventive medical therapy (statins and aspirin) when relying on a CTA imaging strategy. We compared the rate of statins prescription in a patient cohort assessed either with coronary CTA or exercise testing, and evaluated the agreement on medication prescriptions.
Methods: Consecutive patients who underwent coronary CTA and exercise test for suspected CAD were included. Four clinical cardiologists independently analysed each case based on clinical information and the result of either coronary CTA or exercise test. For each case, treatment strategy and prescription were recorded while blinded to the results of the other cardiac test. Treatment strategy was reassessed using the alternative imaging modality three weeks after the first evaluation. 
Results: A total of 113 patients were included. Mean age was 56.7±11.5 years, 52% were males and diabetes were present in 6%. Coronary CTA showed an obstructive epicardial stenosis in 21.4% and any type of atherosclerotic plaque in 54.2%. Functional testing identified ischemia in 9.1%. The use of coronary CTA resulted in higher number of statin (64.9% vs. 44.5%, P},
	issn = {2223-3660},	url = {http://cdt.amegroups.com/article/view/25834}
}